Back to results
Recruiting

Study to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants at Initial Stages of Advanced Parkinson's Disease (EARLY-FOS)

NCT06916507

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Universitaetsklinikum Heidelberg /ID# 274164

Heidelberg, Baden-Wurttemberg, Germany

+12 additional locations

Contact

Medical Information Germany

49 611 1720 1520medinfo.germany@abbvie.com
View on ClinicalTrials.gov
Study to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants at Initial Stages of Advanced Parkinson's Disease (EARLY-FOS) — TrialFind